UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

Bridgette J. Picou, LVN, ACLPN, presented research on the lived experiences of women living with HIV and going through ...

Frequent donors were more likely to have different genetic changes in their blood stem cells, scientists found.

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

SLIM LIVER was the first clinical trial to test semaglutide as a treatment for MASLD in people living with HIV. MASLD, previously known as non-alcoholic fatty liver disease (NAFLD), is a common and ...

Pamela Bjorkman of the California Institute of Technology won the prize for ‘offering new hope in the fight against ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

By analyzing genes encoding B-cell and T-cell receptors, the model could screen for conditions like HIV, type 1 diabetes, and ...

Blood cells and immune cells are made in the bone marrow ... treatable conditions such as HIV infection and herpes. They also include often deadly illnesses such as rabies and Ebola. Depending on the ...